clinical trials

Vistagen, jittery after seeing rivals fail, pauses plan to restart phase 3 anxiety trial pending FDA talks
Vistagen, jittery after seeing rivals fail, pauses plan to restart phase 3 anxiety trial pending FDA talks
Fierce Biotech
VistaGen
FDA
clinical trials
anxiety
PH94B
Flag link:
Oncolytic virus startup TILT raises €22M to advance cancer therapies
Oncolytic virus startup TILT raises €22M to advance cancer therapies
Endpoints
TILT Biotherapeutics
oncolytic viruses
clinical trials
cancer
oncology
Flag link:
GSK's retrospective trial diversity study shows there's more work to do
GSK's retrospective trial diversity study shows there's more work to do
Fierce Biotech
GSK
clinical trials
clinical trial diversity
Flag link:
Idorsia shares sink on ‘unexpected’ failure of drug study
Idorsia shares sink on ‘unexpected’ failure of drug study
BioPharma Dive
Idorsia
clinical trials
clazosenta
Flag link:
J&J clears PhII for rare blood disorder with drug from $6.5B Momenta buyout
J&J clears PhII for rare blood disorder with drug from $6.5B Momenta buyout
Endpoints
JNJ
Momenta
Janssen
nipocalimab
clinical trials
Flag link:
Ex-Shire drug improves outcomes in autoimmune disease, setting Certa on path to phase 3
Ex-Shire drug improves outcomes in autoimmune disease, setting Certa on path to phase 3
Fierce Biotech
Certa Therapeutics
Shire
FT011
autoimmune disease
clinical trials
scleroderma
Flag link:
Amylyx completes subject enrollment in ALS therapy trial
Amylyx completes subject enrollment in ALS therapy trial
Clinical Trials Arena
Amylyx
clinical trials
AMX0035
ALS
Flag link:
Merck Eyes Third Endometrial Cancer Nod for Keytruda
Merck Eyes Third Endometrial Cancer Nod for Keytruda
BioSpace
Merck
Keyruda
clinical trials
endometrial cancer
Flag link:
GSK moves hepatitis B drug into late-stage testing
GSK moves hepatitis B drug into late-stage testing
BioPharma Dive
GSK
bepirovirsen
clinical trials
hepatitis B
Flag link:
mRNA vaccines: Four major clinical trial readouts to watch in 2023
mRNA vaccines: Four major clinical trial readouts to watch in 2023
Clinical Trials Arena
MRNA
clinical trials
vaccines
Moderna Therapeutics
Pfizer
Flu
Roche
BioNTech
melnaoma
genital herpes
Flag link:
Roche Abandons AKT Prostate Cancer Asset
Roche Abandons AKT Prostate Cancer Asset
BioSpace
Roche
AKT inhibitors
Ipatasertib
clinical trials
castration-resistant prostate cancer
prostate cancer
Flag link:
Alphabet's Verily to trial antidepressants
Alphabet's Verily to trial antidepressants
Beckers Hospital Review
Alphabet
Verily
Otsuka
antidepressants
centanafadine
clinical trials
Flag link:
Inovio hopes Ebola vaccine booster data can provide a shot in the arm
Inovio hopes Ebola vaccine booster data can provide a shot in the arm
Fierce Biotech
Inovio
ebola virus
vaccines
clinical trials
Flag link:
Taysha’s GAN Gene Therapy Hits FDA Speedbump
Taysha’s GAN Gene Therapy Hits FDA Speedbump
BioSpace
Taysha Gene Therapies
TSHA-120
axonal neuropathy
clinical trials
gene therapy
FDA
Flag link:
First Wave BioPharma to initiate trial of adrulipase for cystic fibrosis
First Wave BioPharma to initiate trial of adrulipase for cystic fibrosis
Clinical Trials Arena
First Wave Biopharma
clinical trials
cystic fibrosis
FDA
adrulipase
Flag link:
Prothena: Trial data underscores the potential of antibody in treating Alzheimer’s disease
Prothena: Trial data underscores the potential of antibody in treating Alzheimer’s disease
Biopharma Reporter
Protena
clinical trials
Alzheimer's disease
PRX005
Flag link:
Following in Lilly's footsteps, Teva takes 2nd long-acting schizophrenia drug into phase 3
Following in Lilly's footsteps, Teva takes 2nd long-acting schizophrenia drug into phase 3
Fierce Pharma
Teva Pharmaceutical
clinical trials
schizophrenia
Eli Lilly
antipsychotics
Olanzapine
TV-44749
Flag link:
Amgen commits $8m to improve clinical trial diversity
Amgen commits $8m to improve clinical trial diversity
Outsourcing Pharma
Amgen
clinical trials
clinical trial diversity
Bristol Myers Squibb
Winn Award
Flag link:
After 'half-baked' data drop, CureVac releases results on mRNA flu, COVID-19 vaccines in older adults
After 'half-baked' data drop, CureVac releases results on mRNA flu, COVID-19 vaccines in older adults
Fierce Biotech
CureVac
clinical trials
MRNA
vaccines
COVID-19
Flu
GSK
Flag link:
J&J, Legend’s cancer cell therapy has early success in key clinical trial
J&J, Legend’s cancer cell therapy has early success in key clinical trial
BioPharma Dive
JNJ
Legend Biotech
Carvykti
Multiple Myeloma
clinical trials
cell therapy
Flag link:

Pages